Benralizumab Maintains Remission in Asthma in Some, Not All ...Middle East

Medscape - News
Benralizumab Maintains Remission in Asthma in Some, Not All
Achieving and maintaining clinical remission for up to 2 years is feasible for nearly one third of patients with severe eosinophilic asthma receiving benralizumab. Medscape Medical News

Hence then, the article about benralizumab maintains remission in asthma in some not all was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Benralizumab Maintains Remission in Asthma in Some, Not All )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News